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A B S T R A C T
Objectives: This study tested the efficacy of a toothpaste containing enzymes and proteins reflecting those naturally
occurring in saliva which play an important role in maintaining bacterial balance to improve gingival health condition
and reduce supra-gingival plaque formation over a period of 13 weeks as compared to a commercial control toothpaste.
Methods: This study was a double-blind, randomised, parallel group, 3 month home use study in healthy vo-
lunteers. Non-smokers with a mean modified gingival index (MGI) score of between 2.00–2.75 and at least 20
natural teeth, a minimum of 5 teeth in each quadrant were enrolled in the study. At screening, participants
underwent a dental prophylaxis and were issued with a standard fluoride toothpaste and toothbrush to use for 4
weeks. After 4 weeks, participants demonstrating ongoing eligibility were assessed for gingival health and
plaque score and randomised to either test or control toothpaste, which they used at home twice daily. After 13
weeks, gingival health and plaque were re-scored.
Results: 229 participants completed the study. There were no treatment associated adverse events. Plaque and
gingival scores were significantly better in the test group as compared to the control group. Furthermore, in the
test group plaque and gingival scores fell, while those in the control group rose over the 13 week period.
Conclusions: The test toothpaste containing enzymes and proteins demonstrated significant plaque and gingival
benefit compared to the control toothpaste, and was well tolerated.
Clinical significance: Toothbrushing with the test product derived from naturally occurring enzymes and proteins
had a clinical adjunctive improvement on gingival health compared to brushing alone with a commercially
available fluoride toothpaste.
1. Introduction
Gingivitis is highly prevalent worldwide, with 46% of adults showing
evidence of gingival bleeding and calculus (Community Periodontal Index
score of 2), across all age categories [1]. In the UK, the most recent figures
from the Adult Dental Health Survey 2009 demonstrated that 83% of adult
participants exhibited poor oral health, and 50% of participants had sex-
tants with periodontal pocketing of 4mm or more [2]. This figure is similar
to global estimates with current figures from the WHO Global Oral Health
Data Bank showing that 46% of 35–44 year olds have evidence of period-
ontitis [1]. Severe periodontitis is the sixth most prevalent human disease,
according to the 2010 global burden of diseases study, with a standardized
prevalence of 11.2% [3].
Whilst gingivitis does not always progress to periodontitis, evidence
to date has shown that in the majority of cases if gingival inflammation
is prevented, periodontitis is prevented [4]. Gingivitis and periodontitis
are derived from the same inflammatory disease with chronic gingival
inflammation being the response to the presence of microbial biofilms.
The same microbial biofilms are also considered to be the key risk
factor for the onset of periodontitis, or its progression in treated pa-
tients [5]. Periodontitis has been shown to have a negative impact on
oral health quality of life [6,7] and if left untreated, is a major cause of
tooth loss [8,9]. This highlights the importance of effective treatments
for the control of gingivitis, which unlike periodontitis, is reversible.
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One of the most significant risk factors for gingivitis is poor oral
hygiene which results in the accumulation of plaque [10,11]. Dental
plaque is a diverse biofilm that develops as bacteria preferentially at-
tach to surfaces when the environmental conditions are favourable. In
the oral cavity the initial phase of adhesion allows microbes to accu-
mulate in the salivary pellicle that forms on the clean oral surfaces such
as teeth and gingivae [12]. The initial attachment is tenuous and re-
versible but within minutes the bacteria become irreversibly attached.
The ensuing accumulation of bacteria results in the formation of ex-
tracellular polymers which create a sticky hydrated matrix that holds
the cells in close proximity that is difficult to penetrate and/or remove
[13]. Over time the dental plaque biofilm develops into a complex
structure which in health has been shown to provide benefits to the host
such as resisting colonization by pathogens [14]. However, if dental
biofilms are not regularly dispersed or disrupted by self-performed oral
hygiene measures, they become dysbiotic as local conditions favour the
emergence of pathogenic species. Bacteria of a given species can be
present with a variety of phenotypes from rapid growth to dormant
within the same biofilm. Ultimately an environmental shift occurs, re-
sulting in gingival inflammation changes that favour periodontal pa-
thogens [5,13]. So great is the importance of plaque control measures
to contribute to the oral health status of an individual that they have
been emphasized in all workshops on periodontology [15]. Treatments
to prevent or resolve gingivitis are therefore focussed on improving oral
hygiene and reducing dental plaque [16].
Oral hygiene should be practiced daily at home and treatments
should be simple to improve chances of patient compliance. The bed-
rock of plaque removal is achieved by mechanical toothbrushing, twice
daily, toothbrushing being widely promoted and playing a pivotal role
in the prevention of periodontal diseases [17]. A recent meta review
concluded that both manual and power brushes are effective at plaque
removal, with average reductions in baseline plaque levels of 42% and
46%, respectively [18]. However, although the use of a toothbrush and
fluoridated toothpastes is almost universal, the majority of the popu-
lation do not clean their teeth thoroughly enough to prevent plaque
accumulation [15], questioning the clinical effectiveness of mechanical
oral healthcare interventions alone in managing gingivitis. This is
supported by a number of studies [19–22] and systematic reviews [23].
The adjunctive use of an antibacterial agent for plaque control is
therefore of benefit in those participants who are not able to effectively
debride the oral surfaces of supragingival biofilms using mechanical
procedures alone [24]. When used in combination with an adjunctive
agent, toothbrushing reduces the amount of biofilm and disrupts its
structure, allowing for a more effective action of the adjunctive for-
mulation [25].
A number of adjunctive agents for plaque control and prevention of
gingivitis have been developed, either incorporated into the toothpaste
or used as a mouthrinse. In a comprehensive systematic review and
meta-analysis by Serano et al [24] evidence for the efficacy of tooth-
paste formulations containing stannous fluoride (SnF2), triclosan/co-
polymer or chlorhexidine (CHX) as antiplaque agents is provided.
Evidence for the efficacy of triclosan/zinc citrate toothpastes was also
reported in agreement with a previous review [26]. However, the re-
lative merits of oral care products should also consider adverse effects
which have been reported for some agents shown to be effective for
plaque control. It is well-known that CHX causes extrinsic staining [27],
and cetyl pyridinium chloride (CPC), SnF2 and essential oil based for-
mulations have also been shown to result in tooth staining [28–30]. In
addition, triclosan, CHX and essential oil mouthrinses have also been
reported to cause irritation of the oral soft tissues [31–33].
Saliva is known to contain proteins including enzymes and peptides
which have antibacterial effects and are early responders of the innate
immune system targeting invading pathogens [34,35]. Together with
good oral hygiene it is believed that these antibacterial proteins and
peptides keep the levels of pathogenic bacteria low [36]. A fluoride
containing toothpaste utilises some of the salivary proteins with proven
antibacterial effects, its formulation is designed to confer antiplaque
activity. Three of the proteins contained in this toothpaste exhibit en-
zyme activity. Amyloglucosidase and glucose oxidase work together to
produce hydrogen peroxide from polyglucans, and lactoperoxidase in
the presence of sufficient hydrogen peroxide, catalyses the conversion
of thiocyanate to hypothiocyanite. Both hydrogen peroxide and hy-
pothiocyanite are antibacterial compounds which have been shown
previously to target periodontal pathogens [37,38]. Other antibacterial
proteins include immunoglobulins which provide protection against
infection, lactoferrin which is a chelator of iron and inhibits the me-
tabolic activity of several oral pathogens, and lysozyme which hydro-
lyses bonds in the peptidoglycan layer of bacterial cell walls [35,36,39].
It has been shown that treatment with this toothpaste containing these
naturally antibacterial enzymes and proteins increases levels of salivary
hypothiocyanate, hydrogen peroxide and lysozyme, and decreases the
viability of biofilms of oral bacteria in vitro [40]. Thus this toothpaste
strengthens the natural antibacterial systems in the oral cavity, and in a
recent randomised clinical trial was shown to promote the relative
abundance of bacteria associated with periodontal health and decrease
those associated with periodontal disease [38]. In addition, this
toothpaste contains the surfactant Steareth-30, a non ionic polyethylene
glycol ether of stearic acid [41] which is a very effective emulsifier that
stabilises dispersed systems [42], whereas the majority of toothpastes
contain sodium lauryl sulphate (SLS) which has been shown to cause
gingival sloughing in some individuals [43].
The prevalence figures for gingivitis [2] together with the adverse
effects reported in some individuals for some current formulations in-
dicate that the development of new products for the prevention and
treatment of this disease is warranted. It is anticipated that a toothpaste
formulation based on antibacterial components found naturally occur-
ring in saliva, together with fluoride and a neutral surfactant in the
form of Steareth 30 instead of SLS will provide plaque control that is
well tolerated by most patients.
Ideally plaque inhibitory and antiplaque activities of a given for-
mulation should be proven in a home-use, long-term study, randomised
clinical trial (RCT). Further, the agent should be used as an adjunctive
to mechanical plaque control, as described by the conclusions of the
Council of Dental Therapeutics in 1986. The aim of the present study
was to determine the efficacy of a toothpaste containing natural en-
zymes and proteins with toothbrushing as compared to a control
fluoride toothpaste with toothbrushing, in the control of dental plaque
over a 3 month time period.
2. Materials and methods
2.1. Study design and conduct
This study was a double-blind, randomised, parallel group, 3 month
home use study in 229 healthy volunteers. The study investigated the
relative efficacies of two of mechanical and adjunctive agent plaque
control regimens to improve the gingival condition. Regimen one
comprised a toothpaste containing proteins and enzymes (Zendium™-
1450 ppm Sodium fluoride, lactoperoxidase, lactoferrin, colostrum,
amyloglucosidase, glucose oxidase, lactoperoxidase and potassium
thiocyanate) with toothbrushing. Regimen two comprised a commercial
control fluoride toothpaste (Sensodyne Pronamel® – Sodium fluoride
1450 ppm) with toothbrushing. The study was given ethical approval
by the South West-Exeter Research Ethics Committee (Reference: 16/
SW/0190) and was conducted to Good Clinical Practice Guidelines as
described by the Declaration of Helsinki. The study was registered on
the ClinicalTrials.gov database (identifier: NCT03027908). Participant
recruitment, screening, treatment and clinical assessments were carried
out at the study site, a UK Dental School.
Volunteers who expressed an interest in taking part in the study
were invited to the study site for screening and allocated a unique
screening number. To ensure an approximately equal number of males
S. Daly et al. Journal of Dentistry 80 (2019) S26–S32
S27
and females were enrolled in the study, an approximately equal number
were screened and the number of each gender fulfilling the eligibility
criteria monitored. Those participants who were happy to take part in
the study gave written informed consent and were then screened for
eligibility, the study dentist taking a medical history, conducting an
oral soft tissue examination (OST), and performing Modified Gingival
Index (MGI), Bleeding Index (BI) and Plaque Assessments on all
scoreable teeth. Eligible participants were healthy adults 18 years or
over with a mean MGI score of between 2.00–2.75 and at least 20
natural teeth, with a minimum of least 5 teeth in each quadrant.
Exclusion criteria were pregnancy or breast feeding, antibiotic or an-
timicrobial treatment within 4 weeks of the screening appointment,
antihistamine medication within 24 h of the screening appointment,
obvious untreated caries, significant periodontal disease, partial or
complete dentures, oral piercings, ongoing orthodontic treatment and
smoking, including e-cigarettes. Vegans and vegetarians were also ex-
cluded as one of the toothpastes contains ingredients derived from milk
and egg sources. Participants that satisfied the inclusion and exclusion
criteria were enrolled onto the study, given a professional dental pro-
phylaxis and provided with a conventional cosmetic silica fluoride
toothpaste and a toothbrush to use at home, twice daily for 4 weeks. In
addition, participants were asked to refrain from the use of dental
products (other than those provided) during the pre-treatment and test
phases of the study, this included interdental cleaning aids, and parti-
cipants were also asked to abstain from any professional cleaning.
Compliance with all study restrictions was checked at the beginning of
each visit to the study site.
After 4 weeks, participants returned to the study site for the baseline
visit having abstained from toothbrushing or using any oral hygiene
products (mouthwashes, medicated floss or chewing gum) from mid-
night the evening before, and having refrained from eating or drinking
for at least one hour before their study appointment. To confirm on-
going eligibility for the study, a medical history review, OST exam,
MGI, BI and plaque assessments were repeated on all scoreable teeth. At
this appointment any participant with a single MGI score of 3 was
withdrawn from the study. Following baseline assessments, participants
were randomised utilising gender stratification, to one of the two
toothpastes according to the randomisation schedules prepared by the
study statistician.
Randomisation numbers were assigned by study staff in ascending
numerical order as participants were deemed eligible to continue in the
study. Two randomisation schedules were provided, one for males and
the other for females, each schedule designed so that an equal number
of participants of the gender would be allocated to test or control if a
similar number of each were enrolled. For female participants rando-
misation numbers were prefixed by an ‘F’ and for male participants the
prefix was ‘M’. To maintain blinding, randomisation and product dis-
pensing were undertaken in an area completely separate to that in
which the study dentist undertook the clinical assessments. Product
dispensing was carried out by additional study staff, the study dentist
was only told the participant’s randomisation number. To ensure par-
ticipants were blind to the treatment they were receiving their study
toothpaste was provided in a plain white tube labelled with a code
which bore no resemblance to the product names or the words test or
control. Participants were also given a toothbrush (the same for both
groups) and instructed to use the allocated product at home, twice a
day for the duration of the study.
After 13 weeks participants returned to the study site for their final
visit having abstained from toothbrushing or using any oral hygiene
products (mouthwashes, medicated floss or chewing gum) from mid-
night the evening before, and having refrained from eating or drinking
for at least one hour before their study appointment. At this final ap-
pointment a medical history review, OST exam, MGI, BI and plaque
assessments were repeated on all scoreable teeth, and all study products
were returned to the study site.
2.2. Clinical measurements
At each visit, three outcome variables were recorded for each
scoreable tooth. The analyses of efficacy of the toothpastes with
toothbrushing were based on the scores averaged over all the sites of
the scoreable teeth. The primary outcome measure was the MGI [44]
scored on a 5 point scale at 4 sites per tooth (buccal and lingual/palatal
marginal gingivae and interdental papillae). Score 0 = normal (absence
of inflammation), score 1 = mild inflammation (slight change in
colour, little change in texture) on any portion of the gingival unit,
score 2 = mild inflammation of the entire gingival unit, score 3 =
moderate inflammation (moderate glazing, redness, oedema, and/or
hypertrophy) of the gingival unit, score 4 = severe inflammation
(marked redness and oedema/hypertrophy, spontaneous bleeding, or
ulceration) of the gingival unit. The BI [45] was scored on a 3 point
scale at four gingival sites per tooth (distobuccal, midbuccal, mid-
lingual, and mesiolingual); 0 = absence of bleeding after 30 s, 1 =
bleeding after 30 s, 2 = immediate bleeding on probing. The third
outcome measure used was the Plaque Index (Modified Quigley and
Hein) [46] which was scored on a 6 point scale at 3 buccal and 3 lingual
sites per tooth after the teeth had been disclosed with liquid disclosing
solution. Score 0 = no plaque, score 1 = separate flecks of dis-
continuous band of plaque at the gingival margin, score 2 = thick (up
to 1mm), continuous band of plaque at the gingival margin, score 3 =
band of plaque wider than 1mm, but less than one third of surface,
score 4 = plaque covering one third or more, but less than two thirds
surface, score 5 = plaque covering two thirds or more of surface.
2.3. Sample size and statistical analysis
The study was designed to recruit a minimum of 240 consenting
participants who satisfied the eligibility criteria so that at least 200
participants (100 each group) completed the study. This sample size
gives 80% power to detect a difference of 0.4 times the within-groups
standard deviation of the whole-mouth MGI score between the ex-
perimental and control groups at 13 weeks using a two-sided in-
dependent sample t-test at the conventional 5% alpha level.
At each time point, summary statistics were calculated for the test
toothpaste group and the control toothpaste group, for mean scores for
the three measures over all scoreable teeth. Analysis was carried out
both within-groups and between-groups. In the within-groups each of
the above measures were compared between baseline and 13 weeks.
The mean change is reported, with a 95% confidence level and asso-
ciated p-value as determined by paired t-test In the primary, between-
groups, analysis, each of the above measures was compared between
the experimental group and the control group, at 13 weeks, using an
analysis of covariance model with 2 factors, treatment and gender,
using the corresponding baseline value as covariate. The mean differ-
ence is reported, with a 95% confidence level and associated p-value.
3. Results
Recruitment commenced in October 2016 and the study was com-
pleted in April 2017. Participant flow through the study is shown in
Fig. 1. At screening 245 participants of the 261 screened were enrolled
onto the study. At baseline 2 participants were lost to follow up, one
withdrew and 239 participants who demonstrated continued eligibility
were randomised. Following randomisation 10 participants withdrew
from the study so that 229 participants completed the study. There
were 7 non-treatment related adverse events recorded during the study
period. Participant demographics are shown in Table 1. The two
treatment groups were well balanced for age and gender, though ethnic
minorities were more strongly represented in the group allocated to the
test fluoride toothpaste containing natural enzymes and proteins.
Changes from baseline to 13 weeks for both treatment groups for
MGI, BI and plaque score are shown in Table 2. In the control group
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(commercially available fluoride toothpaste) all three measures had
increased by 13 weeks, with the increase in MGI from 1.657 to 1.744,
significant. By contrast, in the test group who used the toothpaste
containing natural enzymes and proteins all three measures decreased
significantly, with the change for MGI and plaque score highly sig-
nificant, reducing from 1.627 and 2.223 to 1.404 and 2.112, respec-
tively.
Comparing the two groups following 13 weeks of product use, all
three measures showed a marked superiority for the test toothpaste
(containing natural enzymes and proteins) treatment over the control
toothpaste as shown in Table 3. For each measure, the difference was
significant before and after adjustment of the means for the baseline
score and gender.
4. Discussion
The present study compared a test fluoride toothpaste, containing
naturally occurring enzymes and proteins, with a commercially avail-
able fluoride control toothpaste. The study demonstrated that tooth-
brushing with the test product resulted in significantly better gingival
and plaque scores compared to toothbrushing with the control tooth-
paste after 13 weeks. Furthermore, gingival and plaque scores increased
from baseline in the control group, and decreased for all measures,
gingival, plaque and bleeding scores, in the test group.
While antibacterial adjuncts can be effectively delivered in mou-
thrinse formulations, these must be administered in addition to the
normal toothbrushing regimen with toothpaste. This may be considered
to be a burden of home dental care, and can easily be omitted.
Furthermore, there is the consideration of chemical interaction between
oral healthcare products which may result in the negation of their re-
spective benefits [47]. The optimal way to deliver antibacterial ad-
juncts is within toothpastes, as this reduces the number of activities
required on the part of the patient as well as reducing the risk of po-
tential chemical interaction. This is achieved by reducing the con-
stituents to proven and prescribed toothpaste formulations where no
Fig. 1. Participant flow through the study.
Table 1
Participant demographics.
All participants
(n= 229)
Fluoride Control®
(n= 116)
Zendium™
(n= 113)
Mean age (min, max) 32.6 (18, 74) 32.2 (19, 74) 33.0 (18, 68)
Gender
Male 119 59 60
Female 110 57 53
Ethnic group
Asian 23 9 14
Black 3 1 2
Caucasian 194 104 90
Hispanic 1 1 0
Mixed 8 1 7
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interactions exist. Further, when antibacterial adjunctive agents are
delivered in combination with the mechanical action of brushing, the
physical disruption of the biofilm improves the access of the anti-
bacterial adjunctive agent to the gingival margin [13].
The incorporation of active ingredients into toothpastes is not
however without its problems, some agents, for example, CHX are
susceptible to inactivation with SLS [47], the most common surfactant
used in toothpastes [41]. To date, evidence from systematic reviews
suggests that only toothpastes containing stannous fluoride (SnF) with
or without sodium hexametaphosphate (SHMP), toothpastes containing
triclosan/copolymer (tric/cop) and toothpastes containing CHX provide
statistically significant improvements in gingival bleeding and plaque
indices as compared to negative controls [17,24,26,48,49]. There is
also some evidence that triclosan/zinc citrate toothpastes are beneficial
for gingival health [26]. The demonstration that the fluoride toothpaste
containing naturally occurring enzymes and proteins tested in this
study is also able to reduce gingival and plaque indices, performing
significantly better than a fluoride control toothpaste, is therefore of
importance. The changes in the gingival indices over 13 weeks observed
for this test toothpaste are in line with those found for the toothpastes
for which significant efficacy for gingival indices over control pastes
has been demonstrated over 26 weeks [24].
The mechanism of action of the fluoride containing test toothpaste
for reducing gingival indices is thought to be via the naturally occurring
enzymes and proteins in its formulation that enable it to augment the
naturally occurring salivary peroxidase system, one of the major de-
fence mechanisms of the oral cavity. In the presence of hydrogen per-
oxide produced by oral bacteria salivary peroxidase catalyses the oxi-
dation of thiocyanate (SCN−) to hypothiocyanite (OSCN−) which
inhibits the growth of bacteria [35,50]. To enhance this natural system,
as well as lactoperoxidase, the test toothpaste contains the enzymes
amyloglucosidase and glucose oxidase which work together to increase
the levels of hydrogen peroxide and thus the conversion of SCN− to
OSCN- by lactoperoxidase. In addition, the toothpaste contains the
salivary enzymes lysozyme and lactoferrin. These proteins have both
bacteriocidal and bacteriostatic activities and it has been shown that
the actions of the three antimicrobial agents lactoperoxidase, lacto-
ferrin and lysozyme are additive [51]. Further, it has been demon-
strated that these enzyme components can be immobilised on the en-
amel pellicle [52].
Support for the ability of the test toothpaste to enhance natural
salivary defences against pathogens has been obtained recently in a
randomised controlled trial where it was demonstrated that this com-
bination of enzymes and proteins promoted a shift in the oral micro-
biome from bacteria associated with periodontal disease to those as-
sociated with periodontal health after 14 weeks of treatment [38]. An
earlier study also provided support for the antimicrobial activity of such
enzyme based toothpastes, demonstrating an increase in resting levels
of OSCN− following 1 month of twice daily use [53]. Further, in an
article included in this issue [40] a series of studies demonstrated that
the test toothpaste used in the present study boosted levels of OSCN−,
hydrogen peroxide and lysozyme in saliva in vitro, interfered with the
membrane integrity of Streptococcus mutans and Fusobacterium nucle-
atum, and reduced oral bacterial viability in both single species and
multi species biofilm models.
Few studies have examined clinical outcomes following treatment
with toothpastes containing naturally occurring enzymes and proteins,
but in a 4 day plaque regrowth study a toothpaste with a similar en-
zyme and protein formulation performed significantly better than a
placebo toothpaste [54]. Similarly, in a more recent study it was de-
monstrated that gingivitis scores decreased over the 8 weeks of the
study following treatment with another similar toothpaste containing
natural enzymes and proteins, although no difference between this
toothpaste, and the control toothpaste was detected [55]. However,
unlike the test toothpaste, the control toothpaste used in the study
contained SLS which has been shown to have an antibacterial effect in
vitro and inhibit plaque re-growth in vivo as compared to a high
fluoride rinse [56,57] and so might be expected to have a positive effect
on gingival health. The data obtained in the present study is also sup-
ported by the findings of Pedersen et al. [58] who demonstrated that in
a study of age and gender matched participants, those who had used a
similar toothpaste containing enzymes and proteins during the previous
year had significantly lower gingival and bleeding scores than those
using an alternative fluoride toothpaste during this time.
In the present study, enrolled individuals were provided with a
professional prophylaxis at screening to reduce the level of existing
gingivitis, following which, participants were given a commercially
available control fluoride toothpaste to use in place of their own for a 4
week run in period. The control fluoride toothpaste, similar to the test
toothpaste, did not contain SLS. No further dental prophylaxis was
given at baseline. This novel approach was designed to reduce the
Hawthorne effect [59] whereby participants perform study related
tasks, such as oral hygiene to a higher level than normal, because they
are participating in a clinical trial. This methodology has the advantage
of engendering the participants’ toothbrushing style in the treatment
phase, to be similar to their normal brushing habits, reducing the
Table 2
Change in MGI, BI and plaque score from Baseline to 13 Weeks.
Mean change Lower CL* Upper CL* t-ratio p-value**
MGI
control toothpaste 0.087 0.043 0.131 3.92 < 0.001
toothpaste with proteins and enzymes −0.223 −0.268 −0.178 −9.90 < 0.001
BI
control toothpaste 0.032 −0.003 0.067 1.80 0.075
toothpaste with proteins and enzymes −0.043 −0.080 −0.007 −2.34 0.021
Plaque
control toothpaste 0.004 −0.038 0.047 0.20 0.841
toothpaste with proteins and enzymes −0.111 −0.162 −0.060 −4.30 < 0.001
* 95% confidence level.
** Paired t-test A negative value indicates improvement while positive values indicate worsening.
Table 3
Comparisons between treatment groups at 13 weeks.
Difference Standard
error
Lower CL* Upper CL* t-ratio p-value
MGI
Adjusted 0.329 0.029 0.272 0.386 11.33 <0.001**
BI
Adjusted 0.081 0.024 0.034 0.129 3.39 <0.001**
Plaque
Adjusted 0.111 0.031 0.051 0.172 3.61 <0.001**
* 95% confidence level.
** ANCOVA. Positive differences indicate superiority of the test product over
the fluoride control.
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Hawthorne effect. In addition, where a dental prophylaxis is carried out
at baseline, it may be difficult to determine whether the plaque control
agent under investigation is effective at prevention, or whether gingi-
vitis therapy can be attributed.
This study was designed to investigate the preventive effect of a
fluoride toothpaste containing enzymes and proteins with regards to
gingival inflammation. As gingival indices and plaque scores decreased
from baseline, this suggests it may be beneficial to consider undertaking
six month studies to investigate its longer term efficacy. In addition, the
choice of a control fluoride toothpaste, with no benefit for gingival
inflammation reduction, as compared to a toothpaste with confirmed
efficacy for the treatment of gingivitis, means that it is not possible to
say that the toothpaste with enzymes and proteins is better than market
leaders in the field, but rather that the test paste is superior to the
conventional over the counter paste evaluated. Further studies to test
the enzyme based toothpaste against toothpastes with confirmed effi-
cacy for gingivitis are required.
The rationale for choosing the control toothpaste in the present
study was that in the marketplace it was readily available, SLS free and
non-foaming to be similar in this respect to the test toothpaste which is
designed as an effective formulation for gingivitis for those who find
SLS based products can result in oral soreness [60]. While oral soreness
and transient soft tissue lesions have been reported by healthy volun-
teers in response to SLS based formulations [43,60], it is recognised that
in the main, problems are encountered in those who suffer from aph-
thous ulcers or recurrent aphthous stomatitis [61,62] suggesting that
this population in particular would benefit from a non-SLS gingivitis
paste. The test toothpaste was well tolerated during the study, a finding
considered to be due to its formulation being based on components that
are found naturally in saliva and the use of the mild surfactant Steareth-
30 which recent in vitro and in vivo studies caused minimal gingival
sloughing as compared to SLS [43]. However, patients were not asked
directly to rate their experience following use of this toothpaste in
terms of satisfaction with the taste or any oral discomfort, this is a study
limitation that should be addressed in future clinical studies.
5. Conclusions
In conclusion, this study demonstrates that toothbrushing with a
toothpaste formulation containing naturally occurring proteins, en-
zymes and Steareth 30, is effective at preventing gingivitis compared to
toothbrushing with a commercially available fluoride toothpaste,
having good antiplaque activity in the absence of side effects.
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